Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;

> Zoetis ($ZTS) has launched a one-year study that will use the Voyce Health Monitor to collect data on pain management in dogs with osteoarthritis. Release

> India's Sequent Scientific acquired Turkey's Topkim, a maker of 67 drugs and vaccines for food animals, for 20.7 million Turkish lira ($7.1 million). Article

> The U.S. State Department announced it has formed a research partnership with Ireland's agriculture industry focused largely on animal nutrition, reproduction and health. Article

> The Texas A&M College of Veterinary Medicine & Biomedical Sciences received $1.2 million from the Department of Homeland Security's Science and Technology Directorate and the Institute for Infectious Diseases to develop a program that will teach animal researchers to commercialize their discoveries. Article

> U.K.-based veterinary drugmaker Tangerine Group plans to open a U.S. subsidiary in Atlanta in February. Article

> France reported its first outbreak of bird flu in 8 years--the strain H5N1, which has killed 22 chickens belonging to a single family. Article

> Australia's Regeneus announced that it has initiated a trial of its cancer vaccine, Kvax, in combination with chemotherapy in 45 dogs with lymphoma, who will be treated at the Small Animal Specialist Hospital in Sydney. Article

> Blue Buffalo is recalling one lot of Cub Size Wilderness Wild Chews Bones due to possible contamination with Salmonella. Release